Who Can Apply: Applicants must:
- Have applied to an APA designated program in psychopharmacology.
- Be an early career licensed psychologist (up to 10 years postdoctoral) in clinical or counseling psychology from programs accredited by the American Psychological Association (APA).
- Have experience with and commitment to working with patients who are experiencing medical problems in addition to psychological problems.
- Have experience in providing interventions/therapy based on theoretical and research-based conceptualizations of patient-problems and disorders.
- Recognize the need to evaluate the potential benefits, limitations, and dangers of introducing and eliminating psychotropic medications as part of patients’ treatment plans.
- Be committed to providing psychological interventions/therapy as the primary treatment for patients.
- Show evidence of enrollment in an APA-designated program before receiving scholarship monies.
- Statement on how candidate fulfills the eligibility requirements and how the candidate will be able to provide enhanced patient care through psychopharmacology training (no more than five pages, one- inch margins, single-spaced, no smaller than 11-point font).
- Two letters of recommendation supporting candidate’s qualifications with reference to the scholarship’s goals.
- Current abbreviated CV (maximum of 10 pages).
Deadline: March 1, 2021
Learn More: https://www.apa.org/apf/funding/katkovsky?tab=1